.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Long-term results from the Infant Aphakia Treatment Study show that secondary intraocular lens (IOL) implantation is an important part of the treatment pathway for some children who undergo unilateral cataract surgery in infancy. In the reported cohort, a substantial proportion of eyes initially managed with aphakia and contact lenses later received a secondary IOL. The study is clinically useful because it places secondary implantation within a planned developmental context rather than viewing it simply as a rescue procedure. Decisions can be influenced by age, ocular growth, family ability to maintain contact-lens correction, refractive trajectory, visual rehabilitation, and the child's overall ocular status. For pediatric surgeons, timing remains individualized, and the presence of adequate capsular and ciliary support must be considered carefully. Long-term follow-up is essential because visual outcomes are determined not only by the IOL procedure itself but also by amblyopia therapy and sustained optical correction. The publication supports a patient-specific approach in which secondary IOL implantation is considered when the benefits of a more permanent optical solution outweigh the risks of another intraocular procedure.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Long-term results from the Infant Aphakia Treatment Study show that secondary intraocular lens (IOL) implantation is an important part of the treatment pathway for some children who undergo unilateral cataract surgery in infancy. In the reported cohort, a substantial proportion of eyes initially managed with aphakia and contact lenses later received a secondary IOL. The study is clinically useful because it places secondary implantation within a planned developmental context rather than viewing it simply as a rescue procedure. Decisions can be influenced by age, ocular growth, family ability to maintain contact-lens correction, refractive trajectory, visual rehabilitation, and the child's overall ocular status. For pediatric surgeons, timing remains individualized, and the presence of adequate capsular and ciliary support must be considered carefully. Long-term follow-up is essential because visual outcomes are determined not only by the IOL procedure itself but also by amblyopia therapy and sustained optical correction. The publication supports a patient-specific approach in which secondary IOL implantation is considered when the benefits of a more permanent optical solution outweigh the risks of another intraocular procedure.
3 weeks back
Discover how catalytic nanozymes redefine autoimmune disease therapy by establishing a physiological redox set-point to restore immune tolerance without broad immunosuppression.
Last week
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back
A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
3 weeks back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month
Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
3 weeks back
